Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

Clinical trial NCT06732388 · RECRUITING

Trial details

NCT number: NCT06732388
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Barrett Esophagus Clinical Stage I Esophageal Adenocarcinoma AJCC v8 Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 Esophageal Adenocarcinoma

Start date: 2026-06-23
Primary completion: 2030-08-01
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.